Vault-13

Krensavage Asset Management, LLC

NEW YORK, NY · CIK 1609251 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$263.2m reported value +2.9% vs Q1 2026
18positions
89.4%in top 10
0 new 4 added 2 reduced 2 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 2,866,138 $41.8m15.88% 15.88% UnchangedShares held: Q3 2025 2.1m, Q4 2025 2.8m, Q1 2026 2.9m, Q2 2026 2.9m
2 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 167,816 $40.4m15.36% 15.36% UnchangedShares held: Q3 2025 167.8k, Q4 2025 167.8k, Q1 2026 167.8k, Q2 2026 167.8k
3 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 69,282 $37.5m14.26% 14.26% ReducedShares held: Q3 2025 97.6k, Q4 2025 91.3k, Q1 2026 84.3k, Q2 2026 69.3k -15.0k -15,000 -17.8%
4 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 524,786 $30.0m11.41% 11.41% UnchangedShares held: Q3 2025 405.4k, Q4 2025 524.8k, Q1 2026 524.8k, Q2 2026 524.8k
5 EXELIXIS INC COM EXEL EXEL 370,693 $20.2m7.66% 7.66% ReducedShares held: Q3 2025 518.5k, Q4 2025 493.5k, Q1 2026 415.7k, Q2 2026 370.7k -45.0k -45,000 -10.8%
6 ABBOTT LABS COM ABT ABT 200,000 $18.1m6.89% 6.89% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.0k, Q2 2026 200.0k +195.0k +195,000 3900.0%
7 SANOFI SPONSORED ADR SNY SNY 323,946 $13.8m5.25% 5.25% UnchangedShares held: Q3 2025 323.9k, Q4 2025 323.9k, Q1 2026 323.9k, Q2 2026 323.9k
8 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 280,681 $13.1m4.96% 4.96% UnchangedShares held: Q3 2025 363.5k, Q4 2025 313.5k, Q1 2026 280.7k, Q2 2026 280.7k
9 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 390,879 $13.1m4.96% 4.96% UnchangedShares held: Q3 2025 0, Q4 2025 149.6k, Q1 2026 390.9k, Q2 2026 390.9k
10 VANDA PHARMACEUTICALS INC COM VNDA VNDA 1,180,388 $7.2m2.74% 2.74% UnchangedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 1.2m
11 BIONTECH SE SPONSORED ADS BNTX BNTX 59,523 $5.5m2.10% 2.10% UnchangedShares held: Q3 2025 79.4k, Q4 2025 99.5k, Q1 2026 59.5k, Q2 2026 59.5k
12 GSK PLC SPONSORED ADR GSK GSK 96,729 $5.1m1.93% 1.93% UnchangedShares held: Q3 2025 271.7k, Q4 2025 96.7k, Q1 2026 96.7k, Q2 2026 96.7k
13 BIOGEN INC COM BIIB BIIB 20,000 $4.3m1.64% 1.64% UnchangedShares held: Q3 2025 10.0k, Q4 2025 10.0k, Q1 2026 20.0k, Q2 2026 20.0k
14 REGENERON PHARMACEUTICALS COM REGN REGN 6,000 $3.7m1.42% 1.42% AddedShares held: Q3 2025 4.0k, Q4 2025 4.0k, Q1 2026 4.0k, Q2 2026 6.0k +2.0k +2,000 50.0%
15 EMBECTA CORP COMMON STOCK EMBC EMBC 1,135,340 $3.7m1.41% 1.41% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 735.3k, Q2 2026 1.1m +400.0k +400,000 54.4%
16 ARDELYX INC COM ARDX ARDX 534,523 $2.7m1.04% 1.04% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 500.0k, Q2 2026 534.5k +34.5k +34,523 6.9%
17 INMODE LTD SHS INMD INMD 120,942 $1.8m0.67% 0.67% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 120.9k, Q2 2026 120.9k
18 EVOLUS INC COM EOLS EOLS 157,985 $1.1m0.42% 0.42% UnchangedShares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 158.0k, Q2 2026 158.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
INDIVIOR PHARMACEUTICALS INC INDV INDV 339,532 $10.3m339.5k shares
ALKERMES PLC ALKS ALKS 107,822 $3.8m107.8k shares